Phase ? Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To evaluate the immunogenicity of administering one dose of influenza virus split vaccine (0.7mL/dose) to individuals aged 60 and above.
Epistemonikos ID: 9f58be1f0b08623583bdf213a0c49cb71ca3204c
First added on: Jan 09, 2026